Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. (ACHC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
achc · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Acadia Healthcare Company, Inc. (ACHC) measures how much investors pay for each dollar of the company's trailing earnings. ACHC's current PE ratio of N/A is calculated by dividing its stock price of $24.48 by its TTM earnings per share of -$12.23.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2010 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 11 fiscal years · Front-end computedMinQ1 · 25%28.3x
MedianQ3 · 75%461.8x
Max
At N/A, ACHC's current P/E is lower than in 0% of its annual fiscal year readings over the past 11 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Acadia Healthcare Company, Inc.You ACHC | $2.3B | N/A | — | -$12.23 |
 Addus HomeCare Corporation ADUS | $1.7B | 20.66x | -72.3% | $5.20 |
 Ardent Health Partners, LLC ARDT | $1.2B | 9.15x | -87.7% | $0.96 |
 Astrana Health, Inc. ASTH | $1.9B | 54.15x | -27.3% | $0.46 |
 Aveanna Healthcare Holdings Inc. AVAH | $1.5B | 7.31x | -90.2% | $1.11 |
 Brookdale Senior Living Inc. BKD | $2.9B | N/A | — | -$1.12 |
 LifeStance Health Group, Inc. LFST | $2.9B | 281.23x | +277.5% | $0.03 |
Industry Average 5 peers with valid PE | — | 74.50x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-12.16 | — | |
2024-12-31 FY2024 | 14.21x | $2.79 | — | |
2023-12-31 FY2023 | — | $-0.24 | — | |
2022-12-31 FY2022 | 27.03x | $3.05 | -4.4% | |
2021-12-31 FY2021 | 28.26x | $2.15 | — | |
2020-12-31 FY2020 | — | $-7.65 | — | |
2019-12-31 FY2019 | 26.72x | $1.24 | — | |
2018-12-31 FY2018 | — | $-2.01 | — | |
2017-12-31 FY2017 | 14.20x | $2.30 | -96.9% | |
2016-12-31 FY2016 | 461.78x | $0.07 | +1198.1% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Acadia Healthcare Company, Inc. (ACHC) measures how much investors pay for each dollar of the company's trailing earnings. ACHC's current PE ratio of N/A is calculated by dividing its stock price of $24.48 by its TTM earnings per share of -$12.23.
Frequently asked questions
ACHC pe ratio · 6 questionsACHC's current PE ratio is N/A as of 2026-06-08, based on a stock price of $24.48 and TTM EPS of -$12.23. Data sourced from Financial Modeling Prep via ACHC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Acadia Healthcare Company, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08